Literature DB >> 20834228

Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo.

Hiroyuki Niida1, Kazuhiro Murata, Midori Shimada, Kumiko Ogawa, Kumiko Ohta, Kyoko Suzuki, Hidetsugu Fujigaki, Aik Kia Khaw, Birendranath Banerjee, M Prakash Hande, Tomomi Miyamoto, Ichiro Miyoshi, Tomoyuki Shirai, Noboru Motoyama, Mireille Delhase, Ettore Appella, Makoto Nakanishi.   

Abstract

Although the linkage of Chk1 and Chk2 to important cancer signalling suggests that these kinases have functions as tumour suppressors, neither Chk1+/- nor Chk2-/- mice show a predisposition to cancer under unperturbed conditions. We show here that Chk1+/-Chk2-/- and Chk1+/-Chk2+/- mice have a progressive cancer-prone phenotype. Deletion of a single Chk1 allele compromises G2/M checkpoint function that is not further affected by Chk2 depletion, whereas Chk1 and Chk2 cooperatively affect G1/S and intra-S phase checkpoints. Either or both of the kinases are required for DNA repair depending on the type of DNA damage. Mouse embryonic fibroblasts from the double-mutant mice showed a higher level of p53 with spontaneous DNA damage under unperturbed conditions, but failed to phosphorylate p53 at S23 and further induce p53 expression upon additional DNA damage. Neither Chk1 nor Chk2 is apparently essential for p53- or Rb-dependent oncogene-induced senescence. Our results suggest that the double Chk mutation leads to a high level of spontaneous DNA damage, but fails to eliminate cells with damaged DNA, which may ultimately increase cancer susceptibility independently of senescence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20834228      PMCID: PMC2964167          DOI: 10.1038/emboj.2010.218

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  61 in total

1.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

Authors:  N H Chehab; A Malikzay; E S Stavridi; T D Halazonetis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.

Authors:  D W Bell; J M Varley; T E Szydlo; D H Kang; D C Wahrer; K E Shannon; M Lubratovich; S J Verselis; K J Isselbacher; J F Fraumeni; J M Birch; F P Li; J E Garber; D A Haber
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

3.  Role of human Cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53.

Authors:  K Tominaga; H Morisaki; Y Kaneko; A Fujimoto; T Tanaka; M Ohtsubo; M Hirai; H Okayama; K Ikeda; M Nakanishi
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

4.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

5.  Dose-dependent biphasic accumulation of TP53 protein in normal human embryo cells after X irradiation.

Authors:  J C Ghosh; Y Izumida; K Suzuki; S Kodama; M Watanabe
Journal:  Radiat Res       Date:  2000-03       Impact factor: 2.841

6.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

Authors:  M Scheffner; B A Werness; J M Huibregtse; A J Levine; P M Howley
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

7.  The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Authors:  S Y Shieh; J Ahn; K Tamai; Y Taya; C Prives
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

8.  The regulation of p53 by phosphorylation: a model for how distinct signals integrate into the p53 pathway.

Authors:  Nicola J Maclaine; Ted R Hupp
Journal:  Aging (Albany NY)       Date:  2009-05-07       Impact factor: 5.682

9.  Chk1 is haploinsufficient for multiple functions critical to tumor suppression.

Authors:  Michael H Lam; Qinghua Liu; Stephen J Elledge; Jeffrey M Rosen
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

10.  Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.

Authors:  S Chellappan; V B Kraus; B Kroger; K Munger; P M Howley; W C Phelps; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

View more
  26 in total

1.  Co-abrogation of Chk1 and Chk2 by potent oncolytic adenovirus potentiates the antitumor efficacy of cisplatin or irradiation.

Authors:  F Ye; Z Yang; Y Liu; D Gong; T Ji; J Wang; B Xi; J Zhou; D Ma; Q Gao
Journal:  Cancer Gene Ther       Date:  2014-05-23       Impact factor: 5.987

Review 2.  Prolonged inflammatory microenvironment is crucial for pro-neoplastic growth and genome instability: a detailed review.

Authors:  Kumari Anuja; Souvick Roy; Chinmoy Ghosh; Priya Gupta; Surajit Bhattacharjee; Birendranath Banerjee
Journal:  Inflamm Res       Date:  2016-09-21       Impact factor: 4.575

3.  Potentiation of the novel topoisomerase I inhibitor indenoisoquinoline LMP-400 by the cell checkpoint and Chk1-Chk2 inhibitor AZD7762.

Authors:  Sheena M Aris; Yves Pommier
Journal:  Cancer Res       Date:  2011-12-21       Impact factor: 12.701

4.  CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute.

Authors:  G Zoppoli; S Solier; W C Reinhold; H Liu; J W Connelly; A Monks; R H Shoemaker; O D Abaan; S R Davis; P S Meltzer; J H Doroshow; Y Pommier
Journal:  Oncogene       Date:  2011-07-18       Impact factor: 9.867

5.  Mahanine, a novel mitochondrial complex-III inhibitor induces G0/G1 arrest through redox alteration-mediated DNA damage response and regresses glioblastoma multiforme.

Authors:  Kaushik Bhattacharya; Arup K Bag; Rakshamani Tripathi; Suman K Samanta; Bikas C Pal; Chandrima Shaha; Chitra Mandal
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

Review 6.  Caspases and cancer.

Authors:  M Olsson; B Zhivotovsky
Journal:  Cell Death Differ       Date:  2011-04-01       Impact factor: 15.828

Review 7.  The MRE11 complex: starting from the ends.

Authors:  Travis H Stracker; John H J Petrini
Journal:  Nat Rev Mol Cell Biol       Date:  2011-02       Impact factor: 94.444

8.  Checkpoint kinase 2 is required for efficient immunoglobulin diversification.

Authors:  Kathrin Davari; Samantha Frankenberger; Angelika Schmidt; Nils-Sebastian Tomi; Berit Jungnickel
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 9.  The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance.

Authors:  Peter Bouwman; Jos Jonkers
Journal:  Nat Rev Cancer       Date:  2012-09       Impact factor: 60.716

10.  Characterization of the role of Fhit in suppression of DNA damage.

Authors:  Joshua C Saldivar; Jessica Bene; Seyed Ali Hosseini; Satoshi Miuma; Susan Horton; Nyla A Heerema; Kay Huebner
Journal:  Adv Biol Regul       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.